Tuberculosis Vaccine

This page contains recent news articles, when available, and an overview of Tuberculosis Vaccine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Tuberculosis Vaccine

Vaccines on horizon for AIDS, Alzheimer's, herpes  -  ‎Nov 17, 2009‎
The Associated PressMARIETTA, Pa. — Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. ...

Crucell Announces Third Quarter 2009 Results  -  ‎Nov 4, 2009‎ (press release)The study is being conducted by the University of Cape Town Lung Institute in conjunction with the South African Tuberculosis Vaccine Initiative. ...

The infectious diseases we face today are relatively tame  -  ‎Nov 20, 2009‎
Bowdoin OrientWith the introduction of the tuberculosis vaccine in the early 20th century, affluent societies were able to cure their populations of the disease. ...

RE: "TB Vaccine in the pipeline"  -  ‎Nov 9, 2009‎
Harare TribuneThe South African Tuberculosis Vaccine Initiative (SATVI) is a research group, located within the Institute of Infectious Disease and Molecular Medicine at ...

Trends Indicate a Move Towards Vaccine Development as Prescription Sales ...  -  ‎Nov 17, 2009‎
Comtex Smartrend11/17/2009-According to an AP report, vaccines for diseases like Malaria, Tuberculosis, Alzheimer's and even AIDS, ...

TB case confirmed  -  ‎Nov 18, 2009‎
DavidsonianThis response can be caused by active tuberculosis as well as previous exposure or a previous tuberculosis vaccine (which is not administered in the United ...

Harvard Among Six Schools Urging Drug Access for Poor  -  ‎Nov 9, 2009‎
BloombergWhen the school licensed a tuberculosis vaccine technology in 2007 to Morningside Group, a Hong Kong-based licensee, the company agreed to sell vaccine ...

DJ EANS-Adhoc: Intercell AG Announces Q3 2009 Results and Updates on R&D ...  -  ‎Nov 8, 2009‎
VisAvis (Pressemitteilung)Tuberculosis vaccine: Phase I/II clinical programs are proceeding according to plan. These programs are based on a partnership between Intercell, ...

Top Health News in 2008  -  Dec 22, 2008
Voice of AmericaBy Melinda Smith As you make up your list of New Year's resolutions for 2009, you might want to include a vow to take better care of your health.

Tuberculosis is closer to home than you think  -  Dec 11, 2008
Georgia Straight,Clinical trials of a new tuberculosis vaccine began earlier this fall in Kenya, according to the WHO, which also notes on its Web site that international

Intercell Update on Technology Partnerships: Intercell Outlicenses ...  -  Dec 19, 2008
PR Newswire (press release),These collaborations include amongst others the development of a tuberculosis vaccine in Phase I clinical trials, which has been partnered with the Danish

Health department investigating possible TB case  -  Dec 16, 2008
Monitor,Anyone who received a tuberculosis vaccine - which is given in some countries outside the United States, including Mexico - may test positive for the

Pentavalent Vaccine Launched For The First Time In Lesotho  -  Dec 22, 2008
Medical News Today (press release),Together with oral polio and BCG (Tuberculosis) vaccine, the Pentavalent combination covers all the vaccine antigens recommended by WHO for administration

New Vaccine Candidate May Better Protect HIV Positive People from TB  -  Oct 24, 2008
Voice of AmericaBy Joe De Capua Human trials are being planned for a new tuberculosis vaccine that's designed to better protect HIV-positive people from TB.

Novel TB Vaccine May Be Safer for HIV-Infected Patients  -  Oct 24, 2008
MedPage Today,By Crystal Phend, Staff Writer, MedPage Today LOS ANGELES, Oct. 24 -- An experimental tuberculosis vaccine with limited ability to replicate may be safer

New UK Science Minister Cites “Future-Telling Power? Among His ...  -  Nov 18, 2008
Discover Magazine,In 2002, when Drayson was still running the company, it recalled its supply of a tuberculosis vaccine after it failed to meet “end of shelf life?

Crucell Announces Third Quarter 2008 Results  -  Nov 10, 2008
MarketWatchThe study is being conducted by the University of Cape Town Lung Institute in conjunction with the South African Tuberculosis Vaccine Institute.

Emergent BioSolutions Reports Financial Results for Third Quarter ...  -  Nov 6, 2008
MarketWatchFormed joint venture with the University of Oxford to develop an advanced tuberculosis vaccine, with funding from Wellcome Trust and Aeras Global TB Vaccine

New hope for TB  -  Oct 28, 2008
Mail & Guardian Online,Six potential vaccines are being developed for human clinical trials, under the aegis of the University of Cape Town's South African Tuberculosis Vaccine

An Irishwoman's Diary  -  Nov 9, 2008
Irish Times,Dr Dorothy Stopford Price (1890-1954) became an internationally renowned expert on childhood tuberculosis, introducing the anti-tuberculosis vaccine, BCG,

Effective TB vaccine for HIV-positive people  -  Oct 24, 2008
HULIQ (press release),At the same time, the only existing tuberculosis vaccine, BCG, should not be used in people with HIV, because it poses a health risk by itself," said Ulrich

New Vaccine Reduces TB Incidence By 37% Among HIV-Positive People ...  -  Oct 24, 2008
Medical News Today (press release),A new tuberculosis vaccine reduced the incidence of the disease by 37% among HIV-positive people during a clinical trial in Tanzania, according to a study

The real superstars  -  Oct 31, 2008,In related news, we heard this week of a possible new tuberculosis vaccine for people with HIV. The research still needs to be replicated,

Daily HIV/Aids Report  -  Oct 24, 2008,A new tuberculosis vaccine reduced the incidence of the disease by 37% among HIV-positive people during a clinical trial in Tanzania, according to a study

Novel tuberculosis vaccine in Germany in clinical phase  -  Sep 12, 2008
Hindu,With the financial support of the BMBF VPM was able to licence the novel tuberculosis vaccine from the Max Planck Institute for Infection Biology.

Clinical trial for new tuberculosis vaccine  -  Sep 15, 2008
The Virtual Medical Centre,..."The BCG tuberculosis vaccine, which was developed by French researchers, is the most frequently administered live vaccine in the world," says Kaufmann.

Funding helps continue TB programmes  -  Sep 10, 2008,Science and Technology (FRST) funding will see AgResearch continue a programme to research the development of a bovine tuberculosis vaccine for possums.

Germans test first new TB vaccine for 80 years  -  Sep 11, 2008
Earthtimes (press release),Berlin - Amid worldwide fears that tuberculosis is adapting to thwart existing drugs, Germany began human testing this week of what is described as the

Tuberculosis Q&A  -  Sep 10, 2008
Press-Enterprise,The tuberculosis vaccine is rarely used in the United States. It is recommended only for those children living with someone who is actively infected and who

Health Bureau attends WHO Regional Committee  -  Sep 24, 2008
Macau Daily Times,...prevention and control of tuberculosis, vaccine-preventable diseases, effects of climate change and strategic plans for dengue prevention and control in

Not-for-profit group gets new funding for TB vaccine research  -  Sep 9, 2008
TropIKA,...government grant for the development of adjuvant combinations specifically designed to enhance the immune response to new tuberculosis vaccine antigens.

TB scare hits campus  -  Sep 11, 2008
LV Campus Times,According to the CDC’s Web site, the tuberculosis vaccine is not readily administered in the United States. Hundreds of ULV students live on campus,

Sinobiomed Retains CB Capital Partners as Financial Advisor to ...  -  Aug 30, 2008 (press release), patent for recombinant human kallikrein-1 (rhK1), and for a Chinese patent for an innovative recombinant multivalent tuberculosis vaccine.

IDRI gets $6.3M grant to study new tuberculosis vaccine  -  Aug 28, 2008
Washington Business Journal,The Infectious Disease Research Institute (IDRI) said it’s been awarded a $6.3 million federal grant to study a new tuberculosis vaccine.

Get a Deep Insight into the World Human Vaccines Market  -  Sep 18, 2008
RedOrbit,II-74 Crucell and AERAS Initiates Tuberculosis Vaccine Clinical Trial II-74 DOR BioPharma Announces Phase I Results of RiVax(TM) II-74 GlaxoSmithKline

Traitement des tuberculoses résistantes, les antibiotiques utilisés  -  Sep 8, 2008
Maroc Info Com,Par ailleurs, un article du Lancet du 12 juillet 2008, intitulé « Tuberculosis vaccine development… », fait le point sur l'immunité anti-Mycobacterium

Experts advise on how TB vaccination candidates can be compared  -  Jul 11, 2008
TropIKA,...(WHO) Initiative for Vaccine Research sponsored three meetings of experts to discuss assay harmonization for new tuberculosis vaccine trials.

Galway News,Supplies of the Tuberculosis vaccine suddenly stopped last September due to a problem with the manufacturing plant in Denmark. BCG supplies only became

Diagnostics-For-All, Harvard Ink Pact to Bring Protein Dx Chips to ...  -  Jul 9, 2008
Biotech Transfer Week,Medicines in Need, known as MEND, to distribute in developing nations an inhalable tuberculosis vaccine developed by Harvard professor David Edwards.

Crawling the Web: Morbidity/Mortality  -  Jul 2, 2008
Scientist Live,..."Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations" Hanekom WA, Dockrell HM, Ottenhoff THM, Doherty TM, Fletcher H,

Gates finds controversy even in works of charity  -  Jun 19, 2008
Rediff,Mr Gates' funding has kick-started drug development partnerships such as the Medicines for Malaria Venture and the Aeras global tuberculosis vaccine

Iomai, Intercell Chief Scientific Officers to Speak on Future of ...  -  Jun 19, 2008
Earthtimes (press release),...vaccine in Phase II, a partnered Tuberculosis vaccine (Phase I/II), and five products focused on infectious diseases in preclinical development.

Sanofi-aventis becomes a major partner in the biotechnology field ...  -  Jun 18, 2008
Newsdesk (pressmeddelande),...such as the Statens Serum Institut of Denmark on a new tuberculosis vaccine to fill a significant unmet medical need around the globe, with Crucell on

IOMAI Acquisition Granted Clearance by US Authorities  -  Jul 11, 2008 (press release),...vaccine in Phase II, a partnered Tuberculosis vaccine (Phase I/II), and five products focused on infectious diseases in preclinical development.

Whole genome identification of Mycobacterium tuberculosis vaccine ...  -  28 May 2008
7thSpace Interactive (press release),Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), infects ~8 million annually culminating in ~2 million deaths.

Experts say science is still a white, male world  -  May 24, 2008
The Times,...a high regard for the strength of scientific expertise of our key developing country partners like the South African Tuberculosis Vaccine Initiative,

Crucell Announces First Quarter 2008 Results  -  May 12, 2008
CNNMoney.comCrucell, the Aeras Global TB Vaccine Foundation and the South African Tuberculosis Vaccine Initiative (SATVI) present encouraging preliminary results from

Intercell AG to Acquire Iomai Corporation to Expand Late Stage ...  -  May 13, 2008
Barron's Blogs...vaccine in Phase II, a partnered Tuberculosis vaccine (Phase I/II), and five products focused on infectious diseases in preclinical development.

Sanofi-aventis: Encouraging First-Quarter 2008 Results Further ...  -  Apr 30, 2008
Earthtimes (press release), pasteur announced the signing of an agreement with Statens Serum Institut for the development and marketing of a new tuberculosis vaccine.

Drug-resistant TB on rise in Britain: study  -  May 1, 2008,A new tuberculosis vaccine has shown promise in animal studies, researchers said on Wednesday, raising hope it might replace the current vaccine that has

Background information on Tuberculosis Vaccine [When available]

[an error occurred while processing this directive]

Search the web for more resources on Tuberculosis Vaccine

Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

The Cancer News Network


Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on lead to other sites. does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is responsible for dead or misdirected links.

We will do our best to accommodate your request.